In this study, the potential protection of mice from MASH development by Fgf15 overexpression alone or in combination with PPARα activation was investigated using an established HFD-induced MASLD mouse model.13 The gene discussed is PPARA; the disease is metabolic dysfunction-associated steatohepatitis.